Exclusion of Liver Disease and Underutilization of Liver-Specific Endpoints in Heart Failure Trials.
- DOI
- 10.1016/j.jchf.2025.03.036
- Published
- 2025 Jul
- Container
- JACC. Heart failure
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jchf.2025.03.036,
title = {Exclusion of Liver Disease and Underutilization of Liver-Specific Endpoints in Heart Failure Trials.},
author = {Khan MS and Rashid AM and Van Spall HGC and Girerd N and Chew NWS and Volk ML and Butler J and Sanyal AJ and Zannad F},
year = {2025},
journal = {JACC. Heart failure},
doi = {10.1016/j.jchf.2025.03.036},
url = {https://doi.org/10.1016/j.jchf.2025.03.036}
}RIS
TY - JOUR TI - Exclusion of Liver Disease and Underutilization of Liver-Specific Endpoints in Heart Failure Trials. AU - Khan MS AU - Rashid AM AU - Van Spall HGC AU - Girerd N AU - Chew NWS AU - Volk ML AU - Butler J AU - Sanyal AJ AU - Zannad F PY - 2025 JO - JACC. Heart failure DO - 10.1016/j.jchf.2025.03.036 UR - https://doi.org/10.1016/j.jchf.2025.03.036 ER -
APA
MS, K., AM, R., HGC, V. S., N, G., NWS, C., ML, V., J, B., AJ, S., & F, Z. (2025). Exclusion of Liver Disease and Underutilization of Liver-Specific Endpoints in Heart Failure Trials.. JACC. Heart failure. https://doi.org/10.1016/j.jchf.2025.03.036